Catheter closure of atrial septal defect in patients with cryptogenic stroke: initial experience in Japan

Yasufumi Kijima1, Teiji Akagi, Manabu Taniguchi

  • 1Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Insights

Catheter closure effectively treats cryptogenic stroke in patients with atrial septal defects (ASD). This safe procedure prevented recurrent neurological events in a Japanese study.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Cardiology

Background:

  • Cryptogenic stroke can be linked to small atrial septal defects (ASD).
  • Limited clinical data exists in Japan regarding ASD closure for stroke prevention.
  • Efficacy and safety of transcatheter closure for these defects remain under investigation.

Purpose of the Study:

  • To evaluate the safety and efficacy of transcatheter closure for interatrial communication in patients with cryptogenic stroke.
  • To assess the reduction or prevention of recurrent neurological events post-procedure.

Main Methods:

  • 13 patients with cryptogenic stroke and interatrial right-to-left shunts underwent transcatheter closure.
  • Transesophageal contrast echocardiography confirmed shunts and assessed closure.
  • Amplatzer Septal Occluder devices were used for closure, with a mean defect size of 9.2 mm.

Main Results:

  • Successful device deployment in all 13 patients.
  • Complete closure achieved in 85% of patients at 12 months.
  • No recurrent thromboembolic events observed during a mean follow-up of 30.1 months.

Conclusions:

  • Transcatheter closure of interatrial right-to-left communications is safe and effective.
  • The procedure shows potential for reducing recurrent neurological events in cryptogenic stroke patients with ASD.